S100A6 Promotes Proliferation of Intrahepatic Cholangiocarcinoma Cells Via the Activation of the P38/mapk Pathway.

Susu Zheng,Hujia Shen,Qingan Jia,Chuyu Jing,Jiajia Lin,Meixia Zhang,Xiaolei Zhang,Boheng Zhang,Yinkun Liu
DOI: https://doi.org/10.2217/fon-2017-0199
2017-01-01
Future Oncology
Abstract:Aim: We explored the expression of S100A6 and its role in intrahepatic cholangiocarcinoma (ICC). Methods: The expression of S100A6 in ICC samples was detected by immunohistochemistry. In vitro experiments, we silenced and overexpressed S100A6 to investigate its role in cell functions. Results: The expression of S100A6 was markedly increased in ICC tissues and cell lines. S100A6 overexpression was an independent risk factor for patients' survival. Silencing S100A6 resulted in a suppression of proliferation and p38/MAPK activity, while overexpressing S100A6 caused a promotion of proliferation and p38/MAPK. Discussion: S100A6 participated in the proliferation of ICC cells and correlated with a more aggressive behavior of ICC. Conclusion: S100A6 may serve as a novel prognostic marker and a potential therapeutic target for ICC patients.
What problem does this paper attempt to address?